1ANG
| CRYSTAL STRUCTURE OF HUMAN ANGIOGENIN REVEALS THE STRUCTURAL BASIS FOR ITS FUNCTIONAL DIVERGENCE FROM RIBONUCLEASE | Descriptor: | ANGIOGENIN | Authors: | Acharya, K.R, Allen, S, Shapiro, R, Riordan, J.F, Vallee, B.L. | Deposit date: | 1994-01-18 | Release date: | 1995-04-20 | Last modified: | 2011-07-13 | Method: | X-RAY DIFFRACTION (2.4 Å) | Cite: | Crystal structure of human angiogenin reveals the structural basis for its functional divergence from ribonuclease. Proc.Natl.Acad.Sci.USA, 91, 1994
|
|
1ALC
| |
1AGI
| |
1BBT
| METHODS USED IN THE STRUCTURE DETERMINATION OF FOOT AND MOUTH DISEASE VIRUS | Descriptor: | FOOT-AND-MOUTH DISEASE VIRUS (SUBUNIT VP1), FOOT-AND-MOUTH DISEASE VIRUS (SUBUNIT VP2), FOOT-AND-MOUTH DISEASE VIRUS (SUBUNIT VP3), ... | Authors: | Acharya, K.R, Fry, E.E, Logan, D.T, Stuart, D.I. | Deposit date: | 1992-05-18 | Release date: | 1994-01-31 | Last modified: | 2024-02-07 | Method: | X-RAY DIFFRACTION (2.6 Å) | Cite: | Methods used in the structure determination of foot-and-mouth disease virus. Acta Crystallogr.,Sect.A, 49, 1993
|
|
6GPB
| |
2QIL
| |
1QIL
| |
1STE
| |
1GPB
| |
1LCL
| CHARCOT-LEYDEN CRYSTAL PROTEIN | Descriptor: | LYSOPHOSPHOLIPASE | Authors: | Acharya, K.R, Leonidas, D.D. | Deposit date: | 1996-01-18 | Release date: | 1997-01-11 | Last modified: | 2024-02-14 | Method: | X-RAY DIFFRACTION (1.8 Å) | Cite: | Crystal structure of human Charcot-Leyden crystal protein, an eosinophil lysophospholipase, identifies it as a new member of the carbohydrate-binding family of galectins. Structure, 3, 1995
|
|
8AGK
| Botulinum neurotoxin subtype A6 cell binding domain in complex with GD1a ganglioside | Descriptor: | 1,2-ETHANEDIOL, Bont/A1, DI(HYDROXYETHYL)ETHER, ... | Authors: | Gregory, K.S, Acharya, K.R, Liu, S.M, Newell, A.R, Mojanaga, O.O. | Deposit date: | 2022-07-20 | Release date: | 2022-09-21 | Last modified: | 2024-01-31 | Method: | X-RAY DIFFRACTION (1.5 Å) | Cite: | Crystal Structures of the Clostridium botulinum Neurotoxin A6 Cell Binding Domain Alone and in Complex with GD1a Reveal Significant Conformational Flexibility. Int J Mol Sci, 23, 2022
|
|
8ALP
| Botulinum neurotoxin A6 cell binding domain crystal form II | Descriptor: | 1,2-ETHANEDIOL, Bont/A1, DI(HYDROXYETHYL)ETHER | Authors: | Gregory, K.S, Acharya, K.R, Liu, S.M. | Deposit date: | 2022-08-01 | Release date: | 2022-09-21 | Last modified: | 2024-01-31 | Method: | X-RAY DIFFRACTION (1.5 Å) | Cite: | Crystal Structures of the Clostridium botulinum Neurotoxin A6 Cell Binding Domain Alone and in Complex with GD1a Reveal Significant Conformational Flexibility. Int J Mol Sci, 23, 2022
|
|
5NJL
| Cwp2 from Clostridium difficile | Descriptor: | Cell surface protein (Putative S-layer protein), SULFATE ION | Authors: | Bradshaw, W.J, Kirby, J.M, Roberts, A.K, Shone, C.C, Acharya, K.R. | Deposit date: | 2017-03-29 | Release date: | 2017-07-05 | Last modified: | 2024-01-17 | Method: | X-RAY DIFFRACTION (1.9 Å) | Cite: | Cwp2 from Clostridium difficile exhibits an extended three domain fold and cell adhesion in vitro. FEBS J., 284, 2017
|
|
5OQ3
| High resolution structure of the functional region of Cwp19 from Clostridium difficile | Descriptor: | 1,2-ETHANEDIOL, CHLORIDE ION, Cwp19, ... | Authors: | Bradshaw, W.J, Kirby, J.M, Roberts, A.K, Shone, C.C, Acharya, K.R. | Deposit date: | 2017-08-10 | Release date: | 2017-11-01 | Last modified: | 2024-01-17 | Method: | X-RAY DIFFRACTION (1.35 Å) | Cite: | The molecular structure of the glycoside hydrolase domain of Cwp19 from Clostridium difficile. FEBS J., 284, 2017
|
|
5OQ2
| Se-SAD structure of the functional region of Cwp19 from Clostridium difficile | Descriptor: | 1,2-ETHANEDIOL, Cwp19, PHOSPHATE ION | Authors: | Bradshaw, W.J, Kirby, J.M, Roberts, A.K, Shone, C.C, Acharya, K.R. | Deposit date: | 2017-08-10 | Release date: | 2017-11-01 | Last modified: | 2017-12-27 | Method: | X-RAY DIFFRACTION (2.3 Å) | Cite: | The molecular structure of the glycoside hydrolase domain of Cwp19 from Clostridium difficile. FEBS J., 284, 2017
|
|
8OW8
| Crystal Structure of the Catalytic Domain of a Botulinum Neurotoxin Homologue from Enterococcus faecium | Descriptor: | 1,2-ETHANEDIOL, Botulinum-like toxin eBoNT/J light chain, PHOSPHATE ION, ... | Authors: | Gregory, K.S, Acharya, K.R, Liu, S.M. | Deposit date: | 2023-04-27 | Release date: | 2023-08-30 | Last modified: | 2023-09-06 | Method: | X-RAY DIFFRACTION (2 Å) | Cite: | Crystal Structure of the Catalytic Domain of a Botulinum Neurotoxin Homologue from Enterococcus faecium : Potential Insights into Substrate Recognition. Int J Mol Sci, 24, 2023
|
|
8QFX
| Human Angiotensin-1 converting enzyme N-domain in complex with the lactotripeptide IPP | Descriptor: | 1,2-ETHANEDIOL, 2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, ... | Authors: | Gregory, K.S, Acharya, K.R, Cozier, G.E. | Deposit date: | 2023-09-05 | Release date: | 2023-11-22 | Last modified: | 2024-02-07 | Method: | X-RAY DIFFRACTION (1.6 Å) | Cite: | Structural insights into the inhibitory mechanism of angiotensin-I-converting enzyme by the lactotripeptides IPP and VPP. Febs Lett., 598, 2024
|
|
8QHL
| Human Angiotensin-1 converting enzyme N-domain in complex with the lactotripeptide VPP | Descriptor: | 1,2-ETHANEDIOL, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, Angiotensin-converting enzyme, ... | Authors: | Gregory, K.S, Cozier, G.E, Acharya, K.R. | Deposit date: | 2023-09-08 | Release date: | 2023-11-22 | Last modified: | 2024-02-07 | Method: | X-RAY DIFFRACTION (1.9 Å) | Cite: | Structural insights into the inhibitory mechanism of angiotensin-I-converting enzyme by the lactotripeptides IPP and VPP. Febs Lett., 598, 2024
|
|
1A4V
| ALPHA-LACTALBUMIN | Descriptor: | ALPHA-LACTALBUMIN, CALCIUM ION | Authors: | Chandra, N, Acharya, K.R. | Deposit date: | 1998-02-05 | Release date: | 1999-04-27 | Last modified: | 2011-07-13 | Method: | X-RAY DIFFRACTION (1.8 Å) | Cite: | Structural evidence for the presence of a secondary calcium binding site in human alpha-lactalbumin. Biochemistry, 37, 1998
|
|
3SEB
| STAPHYLOCOCCAL ENTEROTOXIN B | Descriptor: | STAPHYLOCOCCAL ENTEROTOXIN B | Authors: | Papageorgiou, A.C, Acharya, K.R. | Deposit date: | 1997-11-26 | Release date: | 1998-05-27 | Last modified: | 2011-07-13 | Method: | X-RAY DIFFRACTION (1.48 Å) | Cite: | Crystal structure of microbial superantigen staphylococcal enterotoxin B at 1.5 A resolution: implications for superantigen recognition by MHC class II molecules and T-cell receptors. J.Mol.Biol., 277, 1998
|
|
1B1I
| CRYSTAL STRUCTURE OF HUMAN ANGIOGENIN | Descriptor: | CITRIC ACID, HYDROLASE ANGIOGENIN | Authors: | Leonidas, D.D, Acharya, K.R. | Deposit date: | 1998-11-20 | Release date: | 1999-04-02 | Last modified: | 2023-08-09 | Method: | X-RAY DIFFRACTION (1.8 Å) | Cite: | Refined crystal structures of native human angiogenin and two active site variants: implications for the unique functional properties of an enzyme involved in neovascularisation during tumour growth. J.Mol.Biol., 285, 1999
|
|
1B1Z
| STREPTOCOCCAL PYROGENIC EXOTOXIN A1 | Descriptor: | PROTEIN (TOXIN) | Authors: | Papageorgiou, A.C, Acharya, K.R. | Deposit date: | 1998-11-24 | Release date: | 1999-11-24 | Last modified: | 2023-12-27 | Method: | X-RAY DIFFRACTION (2.57 Å) | Cite: | Structural basis for the recognition of superantigen streptococcal pyrogenic exotoxin A (SpeA1) by MHC class II molecules and T-cell receptors. EMBO J., 18, 1999
|
|
1BKZ
| |
1C5D
| THE CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF A RAT MONOCLONAL ANTIBODY AGAINST THE MAIN IMMUNOGENIC REGION OF THE HUMAN MUSCLE ACETYLCHOLINE RECEPTOR | Descriptor: | MONOCLONAL ANTIBODY AGAINST THE MAIN IMMUNOGENIC REGION OF THE HUMAN MUSCLE ACETYLCHOLINE RECEPTOR | Authors: | Kontou, M, Leonidas, D.D, Vatzaki, E.H, Tsantili, P, Mamalaki, A, Oikonomakos, N.G, Acharya, K.R, Tzartos, S.J. | Deposit date: | 1999-11-17 | Release date: | 1999-12-03 | Last modified: | 2023-08-09 | Method: | X-RAY DIFFRACTION (2.4 Å) | Cite: | The crystal structure of the Fab fragment of a rat monoclonal antibody against the main immunogenic region of the human muscle acetylcholine receptor. Eur.J.Biochem., 267, 2000
|
|
6ZPQ
| |